The use of pethidine and morphine in the presence of monoamine oxidase inhibitors.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D004342:Drug Hypersensitivity / Q000175:diagnosis; D004357:Drug Synergism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D007273:Injections, Intramuscular; D007490:Iproniazid / Q000009:adverse effects; D007520:Isocarboxazid / Q000009:adverse effects; D008297:Male; D008614:Meperidine / Q000009:adverse effects*; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D009020:Morphine / Q000009:adverse effects*; D010624:Phenelzine / Q000009:adverse effects; D014191:Tranylcypromine / Q000009:adverse effects
D008996:Monoamine Oxidase Inhibitors; D007520:Isocarboxazid; D014191:Tranylcypromine; D009020:Morphine; D008614:Meperidine; D007490:Iproniazid; D010624:Phenelzine